Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Health Canada states 6 months to 2 years for Din

<< Previous

Bullboard Posts

Next >>

Comment by Realnewsalways1on Oct 20, 2021 4:14pm

55 Views

Post# 34029056

RE:RE:RE:RE:RE:RE:RE:RE:Health Canada states 6 months to 2 years for Din

Sam the Man, that is their submission. Why would they neeed 4 or 5 applications....Go back to rolling in the mud. Under their submission the timeframe is 180 days as it reads out in HC website. This is not a new drug and this is why they are using 3rd party info.
As I said it is being sold in other countries under other names.

So go back to flipping burgers, break is over

<< Previous

Bullboard Posts

Next >>

This profitable gold stock is on its way up